共 50 条
Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies
被引:0
|作者:
Honda, Hitoshi
[1
]
Sakurai, Yasuo
[2
]
Kang, Jong-Hon
[3
]
Nakamura, Tadahiro
[1
]
Matsuura, Hirotaka
[1
]
Warren, David K.
[4
]
机构:
[1] Teine Keijinkai Med Ctr, Dept Gen Internal Med & Infect Dis, Sapporo, Hokkaido 0068555, Japan
[2] Teine Keijinkai Med Ctr, Dept Radiol, Sapporo, Hokkaido 0068555, Japan
[3] Teine Keijinkai Med Ctr, Ctr Gastroenterol, Sapporo, Hokkaido 0068555, Japan
[4] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
关键词:
Implantable arterial port;
Hepatic malignancies;
Port-related bloodstream infection;
HEPATOCELLULAR-CARCINOMA;
COLORECTAL-CANCER;
LIVER METASTASES;
CHEMOTHERAPY;
INFUSION;
D O I:
10.1016/j.ajic.2013.01.018
中图分类号:
R1 [预防医学、卫生学];
学科分类号:
1004 ;
120402 ;
摘要:
The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days. Copyright (C) 2013 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:930 / 932
页数:3
相关论文